MedTrace Logo

Spinal Cord Stimulation and Physiotherapy for Treatment of Neuropathic Pain

NCT03740763 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-05-23

No results posted yet for this study

Summary

The study evaluates the combined effect of optimized pharmacological treatment, spinal cord stimulation and physiotherapy on pain relief, health-related quality of life and physical function in patients with neuropathic pain. All patients will receive optimized pharmacological treatment before start of spinal cord stimulation treatment. Half of the participants will be randomized to physiotherapy before start of spinal cord stimulation treatment while the other half will start physiotherapy after spinal cord stimulation treatment.

Conditions

  • Neuropathic Pain

Interventions

DEVICE

Spinal Cord Stimulation (SCS)

SCS for treatment of neuropathic pain

OTHER

Physiotherapy

Physiotherapy 2 hours/week with physiotherapist and physical activity counseling for treatment of neuropathic pain

Sponsors & Collaborators

  • Vastra Gotaland Region

    collaborator OTHER_GOV

  • Göteborg University

    lead OTHER

Principal Investigators

  • Paulin Andréll, MD, PhD · Göteborgs Universitet/Västra Götalandsregionen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-09
Primary Completion
2022-05-25
Completion
2023-11-22
FDA Device
Yes

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03740763 on ClinicalTrials.gov